Christopher Moriarty litigates securities fraud and other complex litigation in the United States and consults institutional investors on opportunities to seek recovery in securities-related actions.
In addition to his securities practice, Christopher is part of a team that represents dozens of governmental entities, including states, cities, towns, counties, and townships, in litigation against several pharmaceutical drug manufacturers, distributors, and pharmacies in connection with the opioid epidemic. Notable securities fraud class actions as lead counsel include:
• In re Twitter Inc. Securities Litigation, No. 16-cv-05314-JST (N.D. Cal.) ($809.5 million recovery*) (sole lead counsel) (pending final approval);
• In re Barrick Gold Securities Litigation, No. 13-cv-03851 (S.D.N.Y.) ($140 million recovery*) (sole lead counsel);
• City of Brockton Retirement System v. Avon Products, Inc., 11 Civ. 4655 (PGG) (S.D.N.Y.) ($62 million recovery*) (sole lead counsel);
• Hill v. State Street Corp., No. 09-cv-12136-GAO (D. Mass.) ($60 million recovery*) (co-lead counsel);
• In re Hewlett-Packard Co. Securities Litigation, No. 11-cv-1404 (RNBx) (C.D. Cal.) ($57 million recovery*) (co-lead counsel);
• KBC Asset Management NV v. 3D Systems Corp., No. 15-cv-02393-MGL (D.S.C.) ($50 million recovery*) (co-lead counsel);
• In re Medtronic, Inc. Securities Litigation, No. 0:13-cv-0168 (D. Minn.) ($43 million recovery*) (co-lead counsel);
• Första AP-Fonden and Danske Invest Management A/S v. St. Jude Medical, Inc., Civil No. 12-3070 (JNE/HB) (D. Minn.) ($39.25 million recovery*) (co-lead counsel);
• Ross v. Career Education Corp., No. 12-cv-00276 (N.D. Ill.) ($27.5 million recovery*) (co-lead counsel); and
• KBC Asset Management NV v. Aegerion Pharmaceuticals, Inc., No. 14-cv-10105-MLW (D. Mass.) ($22.25 million recovery*) (co-lead counsel).
Christopher’s securities fraud class action practice encompasses every aspect of litigation, from case-starting to settlement. He has also represented investors in direct actions under the federal securities laws, shareholder derivative litigation, and antitrust class actions; whistleblowers in proceedings before the U.S. Securities and Exchange Commission; and relators in qui tam litigation.
As part of his pro bono practice, Christopher has drafted amicus curiae briefs in approximately 20 constitutional law cases before the U.S. Supreme Court (which has cited his work) and the federal courts of appeal. Outside of his legal practice, Christopher serves on the Board of Directors of Operation Sight, a non-profit that provides free cataract surgery and other services to those in need.
Christopher was called to the Bar in England and Wales by the Honourable Society of the Middle Temple in 2008.
* Please remember that every case is different. Any result we achieve for one client in one matter does not necessarily indicate similar results can be obtained for other clients.
Christopher F. Moriarty, Supreme Court Rules That Securities Act Time Bar Is Not Subject to American Pipe Tolling, Class Action & Derivative Suits Newsletter, American Bar Association (Oct. 3, 2017)
Panelist, Experts: Communicating Complex Ideas and Issues in Litigation Consistent with Messaging Trends, American Bar Association Litigation Section Annual Conference (May 6, 2022)
J.D., Duke University School of Law, 2011
M.A., Trinity College, University of Cambridge, 2007
B.A., Trinity College, University of Cambridge, 2003
- South Carolina
Admitted to Practice Before
U.S. Court of Appeals for the First, Second, Third, Fourth, Fifth, and Tenth Circuits
U.S. District Court for the Northern District of Illinois, the Eastern District of Michigan, and the District of South Carolina
South Carolina Association for Justice
American Bar Association
South Carolina Bar Association
Charleston County Bar Association
Awards and Accolades
2016–2021 South Carolina Super Lawyers® Rising Stars list